Maximilian Mair
@mj-mair.bsky.social
MedOnc Resident MedUni Wien | PostDoc LMU Munich | EANO #Youngsters Committee | EORTC BTG Young Neurooncologist | #neuroonc #braintumors
Excited to be part of this session! 🔬🧠🚀 Looking forward to great discussions at the EANO Youngsters Journal Club - also open to the young-at-heart 😉 @eanoassociation.bsky.social
🧠 Join the next #EANO Youngsters Journal Club! Upcoming session: “Lighting up PET imaging in IDH mutant glioma” [Mair, M., Werner, J. M., Weller, J., et al. (2025), doi.org/10.1093/neuo...
🗓 November 11, 2025 | 🕓 16:30–17:30 CET
👥 Open to all EANO members | Free of charge
🔗 Learn more: www.eano.eu
🗓 November 11, 2025 | 🕓 16:30–17:30 CET
👥 Open to all EANO members | Free of charge
🔗 Learn more: www.eano.eu
November 8, 2025 at 3:52 PM
Excited to be part of this session! 🔬🧠🚀 Looking forward to great discussions at the EANO Youngsters Journal Club - also open to the young-at-heart 😉 @eanoassociation.bsky.social
Reposted by Maximilian Mair
🧠 Join the next #EANO Youngsters Journal Club! Upcoming session: “Lighting up PET imaging in IDH mutant glioma” [Mair, M., Werner, J. M., Weller, J., et al. (2025), doi.org/10.1093/neuo...
🗓 November 11, 2025 | 🕓 16:30–17:30 CET
👥 Open to all EANO members | Free of charge
🔗 Learn more: www.eano.eu
🗓 November 11, 2025 | 🕓 16:30–17:30 CET
👥 Open to all EANO members | Free of charge
🔗 Learn more: www.eano.eu
November 6, 2025 at 8:34 AM
🧠 Join the next #EANO Youngsters Journal Club! Upcoming session: “Lighting up PET imaging in IDH mutant glioma” [Mair, M., Werner, J. M., Weller, J., et al. (2025), doi.org/10.1093/neuo...
🗓 November 11, 2025 | 🕓 16:30–17:30 CET
👥 Open to all EANO members | Free of charge
🔗 Learn more: www.eano.eu
🗓 November 11, 2025 | 🕓 16:30–17:30 CET
👥 Open to all EANO members | Free of charge
🔗 Learn more: www.eano.eu
Reposted by Maximilian Mair
We had a brilliant #EANO2025 Youngsters and CBI session with countless helpful tricks for young investigators! @eanoassociation.bsky.social @maxmastall.bsky.social @mj-mair.bsky.social @galldiks.bsky.social @profajchalmers.bsky.social
October 18, 2025 at 12:20 PM
We had a brilliant #EANO2025 Youngsters and CBI session with countless helpful tricks for young investigators! @eanoassociation.bsky.social @maxmastall.bsky.social @mj-mair.bsky.social @galldiks.bsky.social @profajchalmers.bsky.social
Reposted by Maximilian Mair
The next day of #EANO2025 starts with many valuable insights from the EANO Youngsters-EORTC session on clinical trials! @eanoassociation.bsky.social
October 18, 2025 at 7:16 AM
The next day of #EANO2025 starts with many valuable insights from the EANO Youngsters-EORTC session on clinical trials! @eanoassociation.bsky.social
🧠 Great exchange at our EANO Youngsters - EORTC Joint session at #EANO2025!
🚀 We discussed how collaboration through EORTC supports early-career investigators - and vice versa - plus insights into current brain tumor trials.
Thanks @eortc.org & @eanoassociation.bsky.social!
#NeuroOncology #btsm
🚀 We discussed how collaboration through EORTC supports early-career investigators - and vice versa - plus insights into current brain tumor trials.
Thanks @eortc.org & @eanoassociation.bsky.social!
#NeuroOncology #btsm
October 18, 2025 at 9:53 AM
🧠 Great exchange at our EANO Youngsters - EORTC Joint session at #EANO2025!
🚀 We discussed how collaboration through EORTC supports early-career investigators - and vice versa - plus insights into current brain tumor trials.
Thanks @eortc.org & @eanoassociation.bsky.social!
#NeuroOncology #btsm
🚀 We discussed how collaboration through EORTC supports early-career investigators - and vice versa - plus insights into current brain tumor trials.
Thanks @eortc.org & @eanoassociation.bsky.social!
#NeuroOncology #btsm
Reposted by Maximilian Mair
Still 2 days to #EANO2025! Congratulations to @martinvandenbent.bsky.social, selected for the Best Oral Presentation Award in Clinical research! He’ll present results of the @eortc.org #CATNON trial in Session OS04 on Sat, Oct 18. 👉 www.eano.eu/eano2025/pro...
#BrainTumor #btsm
#BrainTumor #btsm
October 14, 2025 at 10:23 AM
Still 2 days to #EANO2025! Congratulations to @martinvandenbent.bsky.social, selected for the Best Oral Presentation Award in Clinical research! He’ll present results of the @eortc.org #CATNON trial in Session OS04 on Sat, Oct 18. 👉 www.eano.eu/eano2025/pro...
#BrainTumor #btsm
#BrainTumor #btsm
Reposted by Maximilian Mair
Make the most of #EANO2025 – download the official Congress App!
Access the full programme, plan your sessions, connect with fellow attendees, and stay up to date throughout the event.
🔗 Get started: www.eano.eu/eano2025/myc...
#NeuroOncology #BrainTumor #btsm #Prague2025
Access the full programme, plan your sessions, connect with fellow attendees, and stay up to date throughout the event.
🔗 Get started: www.eano.eu/eano2025/myc...
#NeuroOncology #BrainTumor #btsm #Prague2025
October 14, 2025 at 1:54 PM
Make the most of #EANO2025 – download the official Congress App!
Access the full programme, plan your sessions, connect with fellow attendees, and stay up to date throughout the event.
🔗 Get started: www.eano.eu/eano2025/myc...
#NeuroOncology #BrainTumor #btsm #Prague2025
Access the full programme, plan your sessions, connect with fellow attendees, and stay up to date throughout the event.
🔗 Get started: www.eano.eu/eano2025/myc...
#NeuroOncology #BrainTumor #btsm #Prague2025
Reposted by Maximilian Mair
It's #AHPDay2025 and we are very proud to have so many different professions represented at #EANO. Are you a Nurse or Allied Healthcare Professional in Neuro-oncology? Join us!
👉 www.eano.eu/about/about-...
👉 www.linkedin.com/groups/12675...
Or meet us in person at #EANO2025 in Prague!
👉 www.eano.eu/about/about-...
👉 www.linkedin.com/groups/12675...
Or meet us in person at #EANO2025 in Prague!
October 14, 2025 at 7:14 AM
It's #AHPDay2025 and we are very proud to have so many different professions represented at #EANO. Are you a Nurse or Allied Healthcare Professional in Neuro-oncology? Join us!
👉 www.eano.eu/about/about-...
👉 www.linkedin.com/groups/12675...
Or meet us in person at #EANO2025 in Prague!
👉 www.eano.eu/about/about-...
👉 www.linkedin.com/groups/12675...
Or meet us in person at #EANO2025 in Prague!
Reposted by Maximilian Mair
🎉 Congrats to Irma Sakic (UZH) on receiving the #EANO2025 Best Oral Presentation Award in Basic research! She'll present her work on #CRISPR screening & #glioblastoma in KS01, Oct 17.
Learn more and check the full programme 👉 www.eano.eu/eano2025/pro...
#btsm #NeuroOncology
Learn more and check the full programme 👉 www.eano.eu/eano2025/pro...
#btsm #NeuroOncology
October 11, 2025 at 9:36 AM
🎉 Congrats to Irma Sakic (UZH) on receiving the #EANO2025 Best Oral Presentation Award in Basic research! She'll present her work on #CRISPR screening & #glioblastoma in KS01, Oct 17.
Learn more and check the full programme 👉 www.eano.eu/eano2025/pro...
#btsm #NeuroOncology
Learn more and check the full programme 👉 www.eano.eu/eano2025/pro...
#btsm #NeuroOncology
Reposted by Maximilian Mair
Still 3 days to #EANO2025 – and here’s another highlight: Maxine Gorter from @amsterdamumc.bsky.social receives the Best Oral Presentation Award in Supportive care & quality of life research. Congrats! 🎉
🧠 OS01 | Fri, Oct 17
👉 Full programme: www.eano.eu/eano2025/pro...
#NeuroOncology #btsm
🧠 OS01 | Fri, Oct 17
👉 Full programme: www.eano.eu/eano2025/pro...
#NeuroOncology #btsm
October 13, 2025 at 9:16 AM
Still 3 days to #EANO2025 – and here’s another highlight: Maxine Gorter from @amsterdamumc.bsky.social receives the Best Oral Presentation Award in Supportive care & quality of life research. Congrats! 🎉
🧠 OS01 | Fri, Oct 17
👉 Full programme: www.eano.eu/eano2025/pro...
#NeuroOncology #btsm
🧠 OS01 | Fri, Oct 17
👉 Full programme: www.eano.eu/eano2025/pro...
#NeuroOncology #btsm
Reposted by Maximilian Mair
#EANO2025 in Prague is just around the corner! Congrats to Darui Jin from @dkfz.bsky.social, recipient of the Best Oral Presentation Award in Translational Research. Catch the talk in OS12 on Sun, Oct 19: “AI-based histopathological classification...”👉 t1p.de/EANO2025-OS12
#NeuroOncology #AI #btsm
#NeuroOncology #AI #btsm
October 8, 2025 at 1:16 PM
#EANO2025 in Prague is just around the corner! Congrats to Darui Jin from @dkfz.bsky.social, recipient of the Best Oral Presentation Award in Translational Research. Catch the talk in OS12 on Sun, Oct 19: “AI-based histopathological classification...”👉 t1p.de/EANO2025-OS12
#NeuroOncology #AI #btsm
#NeuroOncology #AI #btsm
Reposted by Maximilian Mair
👉 We are excited to announce that the #EANO2025 Abstract Book is now available online! Download & explore it today: lnkd.in/dg79p6wM
#AbstractBook #NeuroOncology #neurosurgery #cancernurse #neuropathology #radiotherapy #AHP #btsm
#AbstractBook #NeuroOncology #neurosurgery #cancernurse #neuropathology #radiotherapy #AHP #btsm
October 6, 2025 at 8:07 PM
👉 We are excited to announce that the #EANO2025 Abstract Book is now available online! Download & explore it today: lnkd.in/dg79p6wM
#AbstractBook #NeuroOncology #neurosurgery #cancernurse #neuropathology #radiotherapy #AHP #btsm
#AbstractBook #NeuroOncology #neurosurgery #cancernurse #neuropathology #radiotherapy #AHP #btsm
🧠 Treating #IDHmutant #glioma can be tricky - watch-and-wait, #vorasidenib, or radiochemo? 🤔
📚 Our new paper in #NeuroOncology shows amino acid #PET adds prognostic value in a large bi-centric cohort (n=457) at @lmu-klinikum.bsky.social & @meduniwien.ac.at. [1/2]
doi.org/p382
📚 Our new paper in #NeuroOncology shows amino acid #PET adds prognostic value in a large bi-centric cohort (n=457) at @lmu-klinikum.bsky.social & @meduniwien.ac.at. [1/2]
doi.org/p382
Prognostic stratification of newly diagnosed IDH-mutant gliomas by [18F]fluoroethyltyrosine and [11C]methionine PET – a retrospective, bicentric cohort study
AbstractBackground. Improved prognostic stratification including imaging-based parameters is needed to guide treatment decisions in IDH-mutant glioma.Metho
doi.org
August 30, 2025 at 2:14 PM
🧠 Treating #IDHmutant #glioma can be tricky - watch-and-wait, #vorasidenib, or radiochemo? 🤔
📚 Our new paper in #NeuroOncology shows amino acid #PET adds prognostic value in a large bi-centric cohort (n=457) at @lmu-klinikum.bsky.social & @meduniwien.ac.at. [1/2]
doi.org/p382
📚 Our new paper in #NeuroOncology shows amino acid #PET adds prognostic value in a large bi-centric cohort (n=457) at @lmu-klinikum.bsky.social & @meduniwien.ac.at. [1/2]
doi.org/p382
Reposted by Maximilian Mair
🚀 #ATTRACT is growing!
⛔️ #ClinicalTrials shouldn’t be limited to a few centers. Therefore, we are expanding our #biobanking to give #glioblastoma patients across #Austria 🇦🇹 access to ATTRACT.
🎉 Milestone: 1st patient enrolled in Wiener Neustadt!
#NeuroOncology #PrecisionMedicine #CancerResearch
⛔️ #ClinicalTrials shouldn’t be limited to a few centers. Therefore, we are expanding our #biobanking to give #glioblastoma patients across #Austria 🇦🇹 access to ATTRACT.
🎉 Milestone: 1st patient enrolled in Wiener Neustadt!
#NeuroOncology #PrecisionMedicine #CancerResearch
August 12, 2025 at 4:15 PM
🚀 #ATTRACT is growing!
⛔️ #ClinicalTrials shouldn’t be limited to a few centers. Therefore, we are expanding our #biobanking to give #glioblastoma patients across #Austria 🇦🇹 access to ATTRACT.
🎉 Milestone: 1st patient enrolled in Wiener Neustadt!
#NeuroOncology #PrecisionMedicine #CancerResearch
⛔️ #ClinicalTrials shouldn’t be limited to a few centers. Therefore, we are expanding our #biobanking to give #glioblastoma patients across #Austria 🇦🇹 access to ATTRACT.
🎉 Milestone: 1st patient enrolled in Wiener Neustadt!
#NeuroOncology #PrecisionMedicine #CancerResearch
Reposted by Maximilian Mair
🧠 Just published in @thelancetoncol.bsky.social: Updated RANO and EANO recommendations on the clinical use of PET imaging in gliomas.
🔗 Read more: www.thelancet.com/journals/lan...
#NeuroOncology #Glioma #PETimaging #EANO #RANO #BrainTumor #LancetOncology
🔗 Read more: www.thelancet.com/journals/lan...
#NeuroOncology #Glioma #PETimaging #EANO #RANO #BrainTumor #LancetOncology
July 29, 2025 at 11:39 AM
🧠 Just published in @thelancetoncol.bsky.social: Updated RANO and EANO recommendations on the clinical use of PET imaging in gliomas.
🔗 Read more: www.thelancet.com/journals/lan...
#NeuroOncology #Glioma #PETimaging #EANO #RANO #BrainTumor #LancetOncology
🔗 Read more: www.thelancet.com/journals/lan...
#NeuroOncology #Glioma #PETimaging #EANO #RANO #BrainTumor #LancetOncology
Reposted by Maximilian Mair
🧠 What is #ATTRACT – and how could it improve #glioblastoma care? This video (🇩🇪 with 🇬🇧 subs) explains how we test 28 drugs on tumor cells & personalize therapy.
Made by @lbg.ac.at w/ Anna Berghoff (ATTRACT Head), @mj-mair.bsky.social (Deputy Head) & Matthias Preusser (Mentor) 🚀
youtu.be/NfxxMZ_xmF4
Made by @lbg.ac.at w/ Anna Berghoff (ATTRACT Head), @mj-mair.bsky.social (Deputy Head) & Matthias Preusser (Mentor) 🚀
youtu.be/NfxxMZ_xmF4
Die KFG ATTRACT
YouTube video by Ludwig Boltzmann Gesellschaft
youtu.be
July 30, 2025 at 4:51 PM
🧠 What is #ATTRACT – and how could it improve #glioblastoma care? This video (🇩🇪 with 🇬🇧 subs) explains how we test 28 drugs on tumor cells & personalize therapy.
Made by @lbg.ac.at w/ Anna Berghoff (ATTRACT Head), @mj-mair.bsky.social (Deputy Head) & Matthias Preusser (Mentor) 🚀
youtu.be/NfxxMZ_xmF4
Made by @lbg.ac.at w/ Anna Berghoff (ATTRACT Head), @mj-mair.bsky.social (Deputy Head) & Matthias Preusser (Mentor) 🚀
youtu.be/NfxxMZ_xmF4
🚀🧠 Exciting science ahead 🔬- follow us for further updates and insights! #glioma #glioblastoma #clinicaltrial #research #btsm #neurooncology #precisionmedicine #oncology
🚀 We’re launching the BlueSky presence of #ATTRACT - a 🇦🇹 Clinical Research Group investigating ex-vivo drug screening 💊 for personalized #glioblastoma treatment, funded by @lbg.ac.at with @meduniwien.ac.at as lead institution.
➡️ Follow us for further insights!
🧠 #GlioblastomaAwarenessDay #NeuroOnc
➡️ Follow us for further insights!
🧠 #GlioblastomaAwarenessDay #NeuroOnc
July 16, 2025 at 4:12 PM
🚀🧠 Exciting science ahead 🔬- follow us for further updates and insights! #glioma #glioblastoma #clinicaltrial #research #btsm #neurooncology #precisionmedicine #oncology
Reposted by Maximilian Mair
🧠 New EORTC survey shows PET imaging is widely available and used across European brain tumour centres.
With data from 103 centres in 20 countries, the findings support PET-based endpoints in future trials.
🔗 Find out more: www.eortc.org/blog/2025/07...
#EORTCbrain #PETImaging
With data from 103 centres in 20 countries, the findings support PET-based endpoints in future trials.
🔗 Find out more: www.eortc.org/blog/2025/07...
#EORTCbrain #PETImaging
July 1, 2025 at 1:18 PM
🧠 New EORTC survey shows PET imaging is widely available and used across European brain tumour centres.
With data from 103 centres in 20 countries, the findings support PET-based endpoints in future trials.
🔗 Find out more: www.eortc.org/blog/2025/07...
#EORTCbrain #PETImaging
With data from 103 centres in 20 countries, the findings support PET-based endpoints in future trials.
🔗 Find out more: www.eortc.org/blog/2025/07...
#EORTCbrain #PETImaging
Reposted by Maximilian Mair
Live from @nmnsymposium.bsky.social in Vienna: introduction of first RANO criteria for response assessment of brain metastases based on amino acid PET - with simultaneous publication in Nature Medicine. Learn more: www.nature.com/articles/s41...
#braincancer #PETimaging
#braincancer #PETimaging
May 9, 2025 at 9:14 AM
Live from @nmnsymposium.bsky.social in Vienna: introduction of first RANO criteria for response assessment of brain metastases based on amino acid PET - with simultaneous publication in Nature Medicine. Learn more: www.nature.com/articles/s41...
#braincancer #PETimaging
#braincancer #PETimaging
Reposted by Maximilian Mair
Are you making an impact in #NeuroOncology research? The #EANOResearchAward honors outstanding contributions in the field. Apply now for a chance to be recognized at #EANO2025 in Prague!
📝 Nomination deadline: May 15
📩 Send your application to: awards@eano.eu
Learn more: www.eano.eu #EANO #btsm
📝 Nomination deadline: May 15
📩 Send your application to: awards@eano.eu
Learn more: www.eano.eu #EANO #btsm
March 20, 2025 at 10:04 AM
Are you making an impact in #NeuroOncology research? The #EANOResearchAward honors outstanding contributions in the field. Apply now for a chance to be recognized at #EANO2025 in Prague!
📝 Nomination deadline: May 15
📩 Send your application to: awards@eano.eu
Learn more: www.eano.eu #EANO #btsm
📝 Nomination deadline: May 15
📩 Send your application to: awards@eano.eu
Learn more: www.eano.eu #EANO #btsm
Reposted by Maximilian Mair
📢 Early Bird Registration open until tomorrow for #NMN2025- register today: www.nmn-society.org/registration/!
February 27, 2025 at 1:18 PM
📢 Early Bird Registration open until tomorrow for #NMN2025- register today: www.nmn-society.org/registration/!
1/3 Excited to share two recent publications! 🧠💡 First, we explored radioligand target expression in high-grade #meningioma, finding #SSTR2a and #FAP variably expressed, with implications for patient selection and radioligand therapy design. @nathaliealbert.bsky.social doi.org/n786
Expression of SSTR2a, FAP, HER2 and HER3 as potential radionuclide therapy targets in higher-grade meningioma - European Journal of Nuclear Medicine and Molecular Imaging
Purpose High-grade meningiomas have high recurrence rates and limited prognosis. Radioligand therapies are approved in extracranial malignancies, but their value in brain tumours including meningiomas...
doi.org
February 24, 2025 at 8:16 AM
1/3 Excited to share two recent publications! 🧠💡 First, we explored radioligand target expression in high-grade #meningioma, finding #SSTR2a and #FAP variably expressed, with implications for patient selection and radioligand therapy design. @nathaliealbert.bsky.social doi.org/n786
Reposted by Maximilian Mair
🤩WOW! A total of 60 abstracts from 18 countries from all around the globe were submitted for #NMN2025! Cutting edge research on gliomas, meningiomas, brain metastases that will advance #PET imaging and #theranostics! Register today and join us: nmn-society.org/registration/!
February 15, 2025 at 10:29 AM
🤩WOW! A total of 60 abstracts from 18 countries from all around the globe were submitted for #NMN2025! Cutting edge research on gliomas, meningiomas, brain metastases that will advance #PET imaging and #theranostics! Register today and join us: nmn-society.org/registration/!
Reposted by Maximilian Mair
Original publication: Measurable disease as baseline criterion for response assessment in glioblastoma: A comparison of PET -based (PET RANO 1.0) and MRI-based (RANO) assessments academic.oup.com/neuro-oncolo....
February 9, 2025 at 9:47 AM
Original publication: Measurable disease as baseline criterion for response assessment in glioblastoma: A comparison of PET -based (PET RANO 1.0) and MRI-based (RANO) assessments academic.oup.com/neuro-oncolo....
Reposted by Maximilian Mair
Temozolomide chemotherapy for patients with newly diagnosed #glioblastoma in the CENTRIC EORTC 26071-22072 and CORE trials: does time of administration matter?https://academic.oup.com/nop/article/doi/10.1093/nop/npaf006/7959516
@neuroonc.bsky.social @eanoassociation.bsky.social @eortc.bsky.social
@neuroonc.bsky.social @eanoassociation.bsky.social @eortc.bsky.social
January 18, 2025 at 9:06 AM
Temozolomide chemotherapy for patients with newly diagnosed #glioblastoma in the CENTRIC EORTC 26071-22072 and CORE trials: does time of administration matter?https://academic.oup.com/nop/article/doi/10.1093/nop/npaf006/7959516
@neuroonc.bsky.social @eanoassociation.bsky.social @eortc.bsky.social
@neuroonc.bsky.social @eanoassociation.bsky.social @eortc.bsky.social